CDC taps Palantir to support COVID-19 drug supply in U.S.

The Centers for Disease Control and Prevention (CDC) has awarded Palantir Technologies a $5.3 million contract to manage distribution of COVID-19 drugs in the United States. The contract for supporting distribution of therapeutics is for a duration of six months, Palantir said. The new partnership is an extension of an existing use of Palantir's Tiberius platform for vaccine distribution, for which the company was selected in 2020.